North American Scientific Poaches Sanarus Chief

Chatsworth, CA-based North American Scientific announced yesterday the appointment of John Rush as president and CEO. The med tech company, which […]

Read more »

FDA Cracks Down on Conflicts of Interest

FDA announced yesterday that it would impose stricter rules upon members of its advisory committees. These committees make recommendations on […]

Read more »

Volcano Erupts

With jordan femme so much talk about dwindling drug-coated stent sales, some smaller med tech firms are primed to take […]

Read more »

Implants Make Top 10

Business 2.0 calls implantable devices one of “The jordan pas cher Top-10 Products, Ideas and Trends” destined to shape the future. While […]

Read more »

Angels Descending

According to a study released yesterday by the air max 97 pas cher University of New Hampshire’s Center for Venture […]

Read more »

Transactions Worth Thinking About

San Francisco I-bank ThinkEquity Partners is out with its latest air max 270 pas cher healthcare newsletter, and it’s rife […]

Read more »

Possis Gets Play in Strib

The air max 270 noir Star Tribune ran a piece over the weekend about drug-device combos. It focused on Coon Rapids, […]

Read more »

Cepheid Xpert at Meningitis Testing

Cepheid, a Sunnyvale, CA molecular diagnostics company,yeezy pas cher got the nod from FDA today to market a rapid test […]

Read more »

PLC Medical Enrolls RenalGuard Trial

PLC Medical Systems has enrolled the cheap trainers uk first patients in its FDA-approved clinical trial designed to evaluate the […]

Read more »

Move Over PDUFA!

Not being as closely scrutinized as the air max 90 homme pas cher pharmaceutical industry has its advantages. But now […]

Read more »